A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.

ABSTRACT: To prioritize circulating metabolites that likely play causal roles in the pathogenesis of multiple sclerosis (MS). Two-sample Mendelian randomization analysis was performed to estimate the causal effects of 571 circulating metabolites on the risk of MS. Genetic instruments for circulating metabolites were obtained from three previous genome-wide association studies (GWAS) of the blood metabolome (N = 7824; 24,925; and 115,078; respectively), while genetic associations with MS were from a large GWAS by the International Multiple Sclerosis Genetics Consortium (14,802 cases and 26,703 control). The primary analysis was performed with the multiplicative random-effect inverse variance-weighted method, while multiple sensitivity analyses were conducted with the weighted median, weighted mode, M

SUBMITTER: Ge A 

PROVIDER: S-EPMC10237183 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature